aiqbench analysis
This article presents EviSearch, a multi-agent system designed to address critical limitations in using large language models for clinical trial evidence extraction, specifically focusing on verification, privacy, and continuous improvement without parameter updates. By utilizing tool-augmented agents with page-level attribution and disagreement-directed human review, the system achieves high accuracy while running entirely offline on open-weight models, offering a robust alternative to proprietary services.
EviSearch: Trustworthy Extraction and Synthesis of Clinical Trial Evidence with Agents that Improve with Use
arXiv:2604.14165v3 Announce Type: replace Abstract: Structured extraction of evidence from clinical trial publications underpins systematic reviews and clinical guidelines, yet large language models are adopted for it only hesitantly: their outputs are difficult to verify, their use commonly requires transmitting documents to proprietary services, and they do not improve from the corrections their users make. We present EviSearch, a multi-agent system that addresses these three obstacles. Three tool-augmented agents with complementary access to a publication extract every column of an evidence table, and a value is admitted only after an attribution verifier has read it on its cited page, so that every value carries a page-level attribution. Disagreement between independent agents directs human review to the cells most likely to be wrong, and reviewer feedback refines the schema definitions and a curation knowledge base without updating model parameters. The agentic system runs entirely offline on open-weight models. On a clinician-annotated benchmark of randomized-trial publications, EviSearch attributes 100.0% of its values, reaches 91.70% accuracy autonomously, and reaches 95.22% after review of 15.6% of cells, exceeding random review of the strongest single agent at equal effort by 1.75 points.
Abstract:Structured extraction of evidence from clinical trial publications underpins systematic reviews and clinical guidelines, yet large language models are adopted for it only hesitantly: their outputs are difficult to verify, their use commonly requires transmitting documents to proprietary services, and they do not improve from the corrections their users make. We present EviSearch, a multi-agent system that addresses these three obstacles. Three tool-augmented agents with complementary access to a publication extract every column of an evidence table, and a value is admitted only after an attribution verifier has read it on its cited page, so that every value carries a page-level attribution. Disagreement between independent agents directs human review to the cells most likely to be wrong, and reviewer feedback refines the schema definitions and a curation knowledge base without updating model parameters. The agentic system runs entirely offline on open-weight models. On a clinician-annotated benchmark of randomized-trial publications, EviSearch attributes 100.0% of its values, reaches 91.70% accuracy autonomously, and reaches 95.22% after review of 15.6% of cells, exceeding random review of the strongest single agent at equal effort by 1.75 points.
12 pages, 6 figures, 3 tables. Substantially revised version: new multi-agent system with attribution verification and disagreement-directed review, new clinician-annotated benchmark and results. Code: this https URL, demo: this https URL
Computation and Language (cs.CL)
arXiv:2604.14165 [cs.CL]
(or arXiv:2604.14165v3 [cs.CL] for this version)
Full text under the publisher's open licence · 225 words
Related coverage
AutoForest: Automatically Generating Forest Plots from Biomedical Studies with End-to-End Evidence Extraction and Synthesis
arXiv · Jun 4, 2026
Quantitative Evidence Mining for Plausibility-Aware Biomedical AI
arXiv · Sep 1, 2026
Enabling a new model for healthcare with AI co-clinician
Google DeepMind · Apr 30, 2026
Responsible Integration of AI in Cancer Genomics: Barriers, Risks, and Pathways to Trustworthy Clinical Translation
arXiv · Sep 1, 2026